Funded Health Care Startups in Cambridge
Across these 40 health care startup rounds, the only disclosed deal above $50M is PineTree Therapeutics’ $47M Series B on 2025-10-30; the next-largest disc…
Across these 40 health care startup rounds, the only disclosed deal above $50M is PineTree Therapeutics’ $47M Series B on 2025-10-30; the next-largest disclosed amounts are materially lower (e.g., Nested Therapeutics $90M is not in this top-20 slice, while within the most recent cluster Cartwheel raised $35M on 2025-08-18 and Owlstone Medical raised $27M on 2025-01-15). On the low end, the smallest disclosed amount is the $20K Grant to Health Tech Enterprise (Cambridge, Cambridgeshire, United Kingdom) on 2022-09-01, creating a wide disclosure range from $20K to $150M (C4 Therapeutics, 2020-06-16).
Dates span 2020-06-16 through 2025-10-30, with a dense 2024 window where multiple entries land between 2024-09-11 and 2024-06-24 (e.g., Holobiome $9M on 2024-10-09; Droplet Biosciences $8M on 2023-03-16; Convergent Therapeutics $22M on 2024-08-13). Geography is split between Cambridge, Massachusetts and Cambridge, Cambridgeshire (UK), and “Series Unknown” appears repeatedly across the period (including BlueShift $80K on 2025-08-15 and LinkGevity marked undisclosed on 2025-03-04), alongside several “undisclosed” rounds (e.g., LinkGevity 2025-03-04; SurgiBox 2024-09-11).
Most recent rounds
40 shownRelated listings
Frequently asked
Which round size is the main outlier in this Cambridge health care set, and how far above the rest is it (using disclosed amounts only)?
C4 Therapeutics’ $150M round on 2020-06-16 is the largest disclosed amount in the 40 rows, while the smallest disclosed amount is $20K (Health Tech Enterprise on 2022-09-01). Even among late-period rounds, PineTree Therapeutics’ largest recent disclosed deal is $47M (2025-10-30), which sits below other large disclosed entries elsewhere in the list (e.g., Apnimed $80M on 2022-12-23; Marengo Therapeutics $80M on 2021-11-08).
Are deals concentrated in a narrow time window, or spread evenly across the 2020–2025 range?
The list runs from 2020-06-16 (C4 Therapeutics) through 2025-10-30 (PineTree Therapeutics), but there is a noticeable mid-range cluster: for example, 2024 includes Holobiome $9M (2024-10-09), SurgiBox (undisclosed) on 2024-09-11, Convergent Therapeutics $22M (2024-08-13), and Heyday Health $13M (2024-06-24).
Does the location split between Cambridge, Massachusetts and Cambridge, Cambridgeshire show a pattern tied to specific deals?
The newest high-value rounds include multiple Cambridge, Massachusetts entries such as PineTree Therapeutics ($47M, 2025-10-30) and Cartwheel ($35M, 2025-08-18). Cambridge, Cambridgeshire (UK) also appears often in 2024–2025 with deals like Owlstone Medical ($27M, 2025-01-15), Natrox ($33M, 2024-12-02), and Maxion Therapeutics ($16M, 2023-02-15).
How often are amounts missing or categorized as unknown, and what does that imply for sizing comparisons?
Several entries do not provide comparable dollar figures: BlueShift is labeled “Series Unknown” with a disclosed amount ($80K, 2025-08-15), while multiple rounds are marked “undisclosed” (e.g., LinkGevity on 2025-03-04; SurgiBox on 2024-09-11; C4 Therapeutics has an “undisclosed” round on 2022-08-15; Hydrow’s $55M (2022-03-17) is not in that missing-price group). Practically, outlier and floor comparisons should rely on disclosed amounts like PineTree Therapeutics’ $47M versus the $20K grant.
What stage mix dominates the dataset, based on the labels shown repeatedly (not just one-offs)?
Stage labeling is heterogeneous, but certain anchors recur: “Series A” appears multiple times across the timeline (Folia Health $11M on 2025-09-29; Goodpath $18M on 2025-09-13; ZWI Therapeutics $10M on 2024-01-24; Maxion Therapeutics $16M on 2023-02-15), while “Series Unknown” also shows up across several years (e.g., Upfront Diagnostics $4M on 2025-05-12; Gensaic $4M on 2023-01-09; LinkGevity is “Series Unknown” with “undisclosed” on 2025-03-04).
Which entries closed within the most recent 90 days shown, and what does that say about recent deal sizes in this list?
Within the most recent 90 days of the rows shown, deals include PineTree Therapeutics ($47M, 2025-10-30), Folia Health ($11M, 2025-09-29), Goodpath ($18M, 2025-09-13), and Cartwheel ($35M, 2025-08-18). The recent disclosed amounts cluster roughly between $11M and $47M, with one much smaller disclosed outlier at $80K (BlueShift, 2025-08-15) and some non-comparable entries where the amount is undisclosed or labeled unknown.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.